Company intelligence
eleva
Next level medicine with ease. Powered by moss.
Biotechnology
Freiburg, DE
51–200 employees
Founded 1999
1 public signals
About eleva
Eleva is a biopharmaceutical company discovering and developing previously inaccessible biological therapeutics. Our clinical-stage, first-in-class Factor H (CPV-104) program aims to bring the benefits of precision complement modulation to patients suffering from severe kidney disorders, dry AMD and other complement-driven diseases. Beyond CPV-104, our mission is to establish a broad pipeline of unique product candidates that benefit from our moss-based technology and expertise in enabling next-generation medicines.
Verified activity
Signals from eleva
1 published signal